Clinical Trial Update: Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD [NA]

View source ↗

Summary

Clinical trial update shows recruitment is ongoing for a lentiviral hematopoietic stem cell gene therapy to treat Metachromatic Leukodystrophy (MLD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metachromatic Leukodystrophy

Drugs mentioned

• Lentiviral hematopoietic stem cell gene therapy for Metachromatic Leukodystrophy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Metachromatic Leukodystrophy (MLD) | NA | Status: RECRUITING